1.Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
Kyunghwan OH ; Hee Seung HONG ; Nam Seok HAM ; Jungbok LEE ; Sang Hyoung PARK ; Suk-Kyun YANG ; Hyuk YOON ; You Sun KIM ; Chang Hwan CHOI ; Byong Duk YE ;
Intestinal Research 2023;21(2):273-273
2.Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
Kyunghwan OH ; Hee Seung HONG ; Nam Seok HAM ; Jungbok LEE ; Sang Hyoung PARK ; Suk-Kyun YANG ; Hyuk YOON ; You Sun KIM ; Chang Hwan CHOI ; Byong Duk YE ;
Intestinal Research 2023;21(1):137-147
Background/Aims:
We investigated the real-world effectiveness and safety of ustekinumab (UST) as induction treatment for Koreans with Crohn’s disease (CD).
Methods:
CD patients who started UST were prospectively enrolled from 4 hospitals in Korea. All enrolled patients received intravenous UST infusion at week 0 and subcutaneous UST injection at week 8. Clinical outcomes were assessed using Crohn’s Disease Activity Index (CDAI) scores at weeks 8 and 20 among patients with active disease (CDAI ≥150) at baseline. Clinical remission was defined as a CDAI <150, and clinical response was defined as a reduction in CDAI ≥70 points from baseline. Safety and factors associated with clinical remission at week 20 were also analyzed.
Results:
Sixty-five patients were enrolled between January 2019 and December 2020. Among 49 patients with active disease at baseline (CDAI ≥150), clinical remission and clinical response at week 8 were achieved in 26 (53.1%) and 30 (61.2%) patients, respectively. At week 20, 27 (55.1%) and 35 (71.4%) patients achieved clinical remission and clinical response, respectively. Twenty-seven patients (41.5%) experienced adverse events, with serious adverse events in 3 patients (4.6%). One patient (1.5%) stopped UST therapy due to poor response. Underweight (body mass index <18.5 kg/m2) (odds ratio [OR], 0.085; 95% confidence interval [CI], 0.014–0.498; P=0.006) and elevated C-reactive protein at baseline (OR, 0.133; 95% CI, 0.022–0.823; P=0.030) were inversely associated with clinical remission at week 20.
Conclusions
UST was effective and well-tolerated as induction therapy for Korean patients with CD.
3.Factors Associated with Clinical Outcomes of Palliative Stenting for Malignant Colonic Obstruction
Sang-Jae KWON ; Jiyoung YOON ; Eun Hye OH ; Jeongseok KIM ; Nam Seok HAM ; Sung Wook HWANG ; Sang Hyoung PARK ; Byong Duk YE ; Jeong-Sik BYEON ; Seung-Jae MYUNG ; Suk-Kyun YANG ; Dong-Hoon YANG
Gut and Liver 2021;15(4):579-587
Background/Aims:
Self-expandable metal stents (SEMSs) can be applied to relieve colorectal obstruction secondary to incurable primary colorectal cancer or extracolonic malignancy. We aimed to identify factors associated with clinical success and the reintervention-free survival (RFS) after palliative stenting.
Methods:
Cases of palliative SEMS placement between 2005 and 2019 were retrieved from the institutional database and reviewed retrospectively. Logistic regression and log-rank testing followed by Cox proportional hazard analyses were performed to investigate the predictors of the clinical success of palliative stenting and factors associated with RFS, respectively.
Results:
A total of 593 patients underwent palliative stenting for malignant colonic obstruction (MCO). The technical and clinical success rates were 92.9% and 83.5%, respectively. Peritoneal carcinomatosis was a predictor of clinical failure (odds ratio, 0.33; 95% confidence interval [CI], 0.17 to 0.65) in the multivariate analysis. Peritoneal carcinomatosis (hazard ratio [HR], 2.48; 95% CI, 1.69 to 3.64) and stent expansion >90% on day 1 (HR, 1.62; 95% CI, 1.05 to 2.50) were associated with a shorter RFS. Neither clinical success nor RFS was associated with extracolonic malignancy. Re-obstruction, stent migration, and perforation were responsible for most reinterventions after clinically successful palliative stenting.
Conclusions
In patients requiring palliative stenting for MCO, peritoneal carcinomatosis was associated with both clinical failure and short RFS. Stent expansion >90% on postprocedural day 1 was another predictor of a short RFS after clinically successful stenting. A large prospective study is warranted to establish factors associated with RFS after successful palliative stenting for MCO.
4.Factors Associated with Clinical Outcomes of Palliative Stenting for Malignant Colonic Obstruction
Sang-Jae KWON ; Jiyoung YOON ; Eun Hye OH ; Jeongseok KIM ; Nam Seok HAM ; Sung Wook HWANG ; Sang Hyoung PARK ; Byong Duk YE ; Jeong-Sik BYEON ; Seung-Jae MYUNG ; Suk-Kyun YANG ; Dong-Hoon YANG
Gut and Liver 2021;15(4):579-587
Background/Aims:
Self-expandable metal stents (SEMSs) can be applied to relieve colorectal obstruction secondary to incurable primary colorectal cancer or extracolonic malignancy. We aimed to identify factors associated with clinical success and the reintervention-free survival (RFS) after palliative stenting.
Methods:
Cases of palliative SEMS placement between 2005 and 2019 were retrieved from the institutional database and reviewed retrospectively. Logistic regression and log-rank testing followed by Cox proportional hazard analyses were performed to investigate the predictors of the clinical success of palliative stenting and factors associated with RFS, respectively.
Results:
A total of 593 patients underwent palliative stenting for malignant colonic obstruction (MCO). The technical and clinical success rates were 92.9% and 83.5%, respectively. Peritoneal carcinomatosis was a predictor of clinical failure (odds ratio, 0.33; 95% confidence interval [CI], 0.17 to 0.65) in the multivariate analysis. Peritoneal carcinomatosis (hazard ratio [HR], 2.48; 95% CI, 1.69 to 3.64) and stent expansion >90% on day 1 (HR, 1.62; 95% CI, 1.05 to 2.50) were associated with a shorter RFS. Neither clinical success nor RFS was associated with extracolonic malignancy. Re-obstruction, stent migration, and perforation were responsible for most reinterventions after clinically successful palliative stenting.
Conclusions
In patients requiring palliative stenting for MCO, peritoneal carcinomatosis was associated with both clinical failure and short RFS. Stent expansion >90% on postprocedural day 1 was another predictor of a short RFS after clinically successful stenting. A large prospective study is warranted to establish factors associated with RFS after successful palliative stenting for MCO.
5.Unexpected Exposure to Coronavirus Disease at the Endoscopic Room: What Should We Do?
Hyun Jeong KIM ; Yong Hwan KWON ; Seong Woo JEON ; Su Yeon NAM ; Hyun Suk LEE ; Joon Seop LEE ; Chang Min CHO ; Ki Tae KWON ; Ji Yeon HAM ; Changho KIM
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020;20(3):248-250
6.Effects of Death Preparation Education on Awareness of Hospice Palliative Care and Withdrawing Life Sustaining Treatment in City Dwellers.
Pei Ling TSUNG ; Yoon Joo LEE ; Su Yeon KIM ; Seul Ki KIM ; Si Ae KIM ; Hyeon Ji KIM ; Yi NAM ; Suk Young HAM ; Kyung Ah KANG
Korean Journal of Hospice and Palliative Care 2015;18(3):227-234
PURPOSE: This study was done to analyze how a death preparation education program have the effects on awareness of hospice palliative care and withdrawing life sustaining treatment in older adults. METHODS: This study employed a non-equivalent control group design among quasi-experimental designs. The experimental group was comprised with 35 adults and the control group with 40 adults. The death preparation program consisted of five two-hour sessions and was administered once a week for five straight weeks. Data were analyzed by descriptive statistics, t-test, chi2 test, Fisher's exact test, and ANCOVA using SPSS version 18.0. RESULTS: The mean age of the participants was 66.2 years. A significant difference between the experimental and control groups was observed in withdrawing life sustaining treatment (F=3.380, P=0.040). However, no significant difference was found in awareness of hospice palliative care (F=0.163, P=0.850). CONCLUSION: The study results indicate that death preparation training could positively affect people's awareness of withdrawing life sustaining treatment. More studies should be conducted to explore effects of death preparation education for all ages and help people better understand hospice palliative care.
Adult
;
Education*
;
Hospices*
;
Humans
;
Life Support Care
;
Palliative Care*
7.Effect of Rivaroxaban on Fibrinolytic Therapy in Massive Pulmonary Embolism: Two Cases.
Hye Jin KIM ; So My KOO ; Nam Suk HAM ; Ki Up KIM ; Soo taek UH ; Yang Ki KIM
Tuberculosis and Respiratory Diseases 2014;76(3):127-130
The risk of dying from a pulmonary embolism (PE) is estimated to be about 30% if inotropic support is required and no cardiopulmonary arrest occurs. Fibrinolysis in massive PE is regarded as a life-saving intervention, unless there is a high risk of bleeding following the use of the fibrinolytic therapy. Rivaroxaban is an oral factor Xa inhibitor, however its anticoagulation effects before or after administration of fibrinolytics in massive PE are still unknown. Two patents were admitted: 61-year-old woman with repeated syncope, and a 73-year-old woman was admitted with dyspnea and poor oral intake. Systemic arterial hypotension with radiologic confirmation led to a diagnosis of massive PE in both patients. Rivaroxaban was administered before in one, and after firbrinolytic therapy in the other. One showed similar efficacy of rivaroxaban with currently used anticoagulants after successful fibrinolysis, and the other one without antecedent administration of the fibrinolytic agent showed unfavorable efficacy of rivaroxaban.
Aged
;
Anticoagulants
;
Diagnosis
;
Dyspnea
;
Factor Xa
;
Female
;
Fibrinolysis
;
Heart Arrest
;
Hemorrhage
;
Humans
;
Hypotension
;
Middle Aged
;
Pulmonary Embolism*
;
Syncope
;
Thrombolytic Therapy*
;
Rivaroxaban
8.Congenital Cardiopulmonary Anomalies in Infants with Recurrent Stridor and/or Respiratory Distress: Report of 3 Cases.
Hyo Kyoung NAM ; Kyong Suk LA ; Jung Hye BYEON ; Ic Sun CHOI ; Gi Young JANG ; Young YOO ; Ji Tae CHOUNG ; Chang Sung SON ; Soo Youn HAM
Pediatric Allergy and Respiratory Disease 2009;19(2):183-190
Although laryngomalacia is the most common cause of congenital stridor in infancy, it is a benign, self-limited disease which usually resolves by the age of 18 months with no long- term sequelae. Nevertheless, infants who suffered from recurrent stridor and respiratory distress should be evaluated for other causes of stridor such as cardiopulmonary anomalies. We report 3 cases of infants who had recurrent stridor and respiratory distress from their early infancy. Case 1 had a double aortic arch and a tracheomalacia, case 2 had a hypoplasia of the right lung, and case 3 had a horseshoe lung as well as scimitar syndrome. Physicians should be alert for the possibility of the congenital cardiopulmonary abnormalities in infants with recurrent stridor and/or respiratory distress.
Aorta, Thoracic
;
Dyspnea
;
Humans
;
Infant
;
Laryngomalacia
;
Lung
;
Respiratory Sounds
;
Scimitar Syndrome
;
Tracheomalacia
9.A Case of Kaposi Sarcoma of the Bronchi and Gastrointestinal Tract in an AIDS Patient.
Kyung Deuk HONG ; Seong Woo NAM ; Seong Eun LEE ; Hyoung Shik SHIN ; Nak Hyun KWON ; Hye Jin NOH ; Se Woon HAM ; Hyun Il CHUNG ; Kwang Joon CHOI ; Hyo Sung KANG ; Kee Suk NAM ; Jung IL SUH
Journal of the Korean Geriatrics Society 2007;11(3):157-161
Kaposi sarcoma is a rare tumor originated from skin in patients with immune suppressive illness like as acquired immunodeficiency syndrome (AIDS) or organ transplantation. It may be widely disseminated internally such as digestive or respiratory organ. In Korean patients with AIDS, Kaposi sarcoma is rarely seen rather than western countries. The reason is unknown. Although few cases of Kaposi sarcoma in patients with AIDS had been described in the Korean literatures, multi-organ involved cases were extremely rare. We describe a case of old AIDS patient in whom Kaposi sarcoma had affected multi-organs including esophagus, stomach, duodenum, colon, bronchi and skin.
Acquired Immunodeficiency Syndrome
;
Bronchi*
;
Colon
;
Duodenum
;
Esophagus
;
Gastrointestinal Tract*
;
Humans
;
Organ Transplantation
;
Sarcoma, Kaposi*
;
Skin
;
Stomach
;
Transplants
10.A Case of Pancreaticobiliary Duct Obstruction due to Pancreatic Tuberculosis Combined with a Colon Adenocarcinoma and Tuberculous Colitis.
Lae Seok HWANG ; Seong Woo NAM ; Seong Eun LEE ; Nak Hyun KWON ; Hyo Sung KANG ; Sung Hoon KIM ; Kee Suk NAM ; Kyung Deuk HONG ; Se Woon HAM ; Young Woong JEON ; Se Hyuk PARK ; Sung Chan JIN ; Hae Sun AHN
Korean Journal of Gastrointestinal Endoscopy 2007;35(4):267-271
Systemic manifestation of tuberculosis is common, but tuberculous biliary obstruction of the pancreas and a colon adenocarcinoma with combined colonic tuberculosis is an uncommon disorder. We encountered a case of the above condition in 63-year-old male that was admitted to our hospital because of fever, diffuse abdominal pain and rigidity. Abdominal computed tomography showed biliary and pancreatic duct dilatation with left colonic wall thickening and surrounding peritoneal infiltration. Emergency segmental resection of the descending colon with intraoperative T-tube choledochostomy was performed due to the colon mass and biliary obstruction. A colonofiberoscopy was performed for low abdominal pain and hematochezia at 12 days after surgery. It showed multiple colonic ulcerations with a partial stricture. A colonic biopsy showed granulomatous inflammation with acid-fast bacilli. The cause of the biliary obstruction was also revealed as pancreatic tuberculosis by an intraoperative pancreatic and mesenteric biopsy. The patient improved after antituberculous treatment and the patient has been in good health until the last outpatient follow-up visit.
Abdominal Pain
;
Adenocarcinoma*
;
Biopsy
;
Choledochostomy
;
Colitis*
;
Colon*
;
Colon, Descending
;
Colonic Neoplasms
;
Constriction, Pathologic
;
Dilatation
;
Emergencies
;
Fever
;
Follow-Up Studies
;
Gastrointestinal Hemorrhage
;
Humans
;
Inflammation
;
Male
;
Middle Aged
;
Outpatients
;
Pancreas
;
Pancreatic Ducts
;
Tuberculosis*
;
Ulcer

Result Analysis
Print
Save
E-mail